BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4618072)

  • 1. [Action of 17-monochloro-acetylajmaline, a new anti-arrhythmia drug, upon myocardial contractility].
    Bardet J; Roudy G; Rocha P; Riguad M; Mathivat A; Bourdarias JP
    Ann Cardiol Angeiol (Paris); 1974; 23(6):539-44. PubMed ID: 4618072
    [No Abstract]   [Full Text] [Related]  

  • 2. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW; Boyksen D
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
    Femmer K; Grünheid K
    Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polygraphic study of the effects on myocardial contractility of a new anti-arrhythmic drug: N-propyl-ajmaline bitartrate].
    De Luca I; Cristallo E; Landriscina B; Gianfrate P; Albanese P; Bacca F
    Boll Soc Ital Cardiol; 1975; 20(4):335-41. PubMed ID: 1231913
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol].
    Terhaag B; Förster W; Mest HJ; Schrör K
    Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic action of propafenon in patients with atherosclerotic coronary disease].
    Lamounier EN; Martinez Filho EE; Herrmann JL; Guimarães RD; Portugal OP; Barcellini A
    Arq Bras Cardiol; 1979 Jul; 33(1):73-6. PubMed ID: 526178
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of a new antiarrhythmic drug.
    Rydén L
    Acta Med Scand Suppl; 1974; 569():1-40. PubMed ID: 4533723
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of antiarrhythmic agents on diastolic stimulation threshold in human heart].
    Heinz N
    Arzneimittelforschung; 1971 Aug; 21(8):1189-91. PubMed ID: 5110017
    [No Abstract]   [Full Text] [Related]  

  • 9. A new potentially antianginal benzofuran with an amiodarone-like pharmacological profile.
    Charlier R; Bauthier J
    Arzneimittelforschung; 1973 Sep; 23(9):1305-11. PubMed ID: 4801226
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of antiarrhythmic drugs on the exercise-ecg (author's transl)].
    Raff U; Hepp A
    Z Kardiol; 1977 Feb; 66(2):61-5. PubMed ID: 842073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of N-(n-propyl)-ajmalinium-hydrogentartrate on canine hemodynamics].
    Mertens HM; Schelbert HR; Kreuzer H; Spiller P; Schmiel FK
    Arzneimittelforschung; 1973 May; 23(5):642-5. PubMed ID: 4740203
    [No Abstract]   [Full Text] [Related]  

  • 12. [The modification of some circulatory indices by iproveratril].
    Karobath H
    Wien Klin Wochenschr; 1966 May; 78(19):351-2. PubMed ID: 5988353
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac actions of 17-monochloroacetylajmaline, N-propylajmaline and ajmaline as studied in the heart-lung preparatins of the dog.
    Katano Y; Otorii T; Maruyama S; Kawai Y; Imai S
    Arzneimittelforschung; 1973 Mar; 23(3):483-4. PubMed ID: 4740139
    [No Abstract]   [Full Text] [Related]  

  • 14. [Screening of substances with coronary vasodilator action].
    Lenke D
    Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic properties of a new derivative of theophylline: bamifylline].
    Moret PR; Fournet PC; Boufas D
    Schweiz Med Wochenschr; 1970 Mar; 100(10):462-7. PubMed ID: 5423732
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the administration of vasodilator agents following pacemaker implantation].
    Wolner E; Mösslacher H
    Z Kreislaufforsch; 1968 Mar; 57(3):213-23. PubMed ID: 4970182
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacologic differentiation between various anti-arrhythmics in animal experiments].
    Lillie C; Kobinger W
    Adv Clin Pharmacol; 1978; 16():3-16. PubMed ID: 28644
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modifications of the inotropic effect of ajmalin in a healthy subject. Comparison of the quinidine and procainamide effect].
    Bruno L; Giani P; Bellinvia P
    Folia Cardiol; 1969; 28():1-10. PubMed ID: 5409244
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of a new antiarrhythmic drug, Craviten (M-71) on coronary flow.
    Banaszkiewicz W; Chodera A
    Pol J Pharmacol Pharm; 1980; 32(6):849-53. PubMed ID: 6787574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
    Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.